These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7472606)

  • 1. Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.
    Okada RD; Nguyen KN; Lauinger M; Allton IL; Spreitzer K; Beju D; Johnson G
    J Nucl Med; 1995 Nov; 36(11):2103-9. PubMed ID: 7472606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
    Okada DR; Liu Z; Beju D; Okada RD; Johnson G
    Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
    Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
    J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium.
    Johnson G; Allton IL; Nguyen KN; Lauinger JM; Beju D; Pasqualini R; Duatti A; Okada RD
    J Nucl Cardiol; 1996; 3(1):42-54. PubMed ID: 8799227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.
    Okada RD; Nguyen KN; Lauinger M; Allton IL; Johnson G
    Am Heart J; 1996 Jul; 132(1 Pt 1):108-15. PubMed ID: 8701850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between uptake of technetium-99m Q12 and thallium-201: myocardial perfusion and viability in a model of acute coronary reperfusion.
    Takahashi N; Reinhardt CP; Marcel R; Leppo JA
    J Nucl Med; 1998 Jan; 39(1):159-65. PubMed ID: 9443756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HL-91-technetium-99m: a new marker of viability in ischemic myocardium.
    Okada RD; Johnson G; Nguyen KN; Carlson LR; Beju D
    J Nucl Cardiol; 1999; 6(3):306-15. PubMed ID: 10385186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.
    Liu Z; Barrett HH; Stevenson GD; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Pak KY
    J Nucl Med; 2004 Jul; 45(7):1251-9. PubMed ID: 15235074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
    Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.
    Liu Z; Johnson G; Beju D; Okada RD
    J Nucl Cardiol; 2001; 8(6):677-86. PubMed ID: 11725264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
    Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.
    Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD
    Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
    Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD
    J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion.
    Johnson G; Nguyen KN; Liu Z; Okada RD
    J Nucl Cardiol; 1998; 5(3):285-94. PubMed ID: 9669583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
    McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
    Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ouabain on technetium-99m-Q12 and thallium-201 extraction and retention by isolated rat heart.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Washburn LC; Millard RW
    J Nucl Med; 1996 May; 37(5):752-6. PubMed ID: 8965140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
    Beller GA; Glover DK; Edwards NC; Ruiz M; Simanis JP; Watson DD
    Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of technetium-99m Q12 and thallium-201 myocardial activity measurements after triphenyl tetrazolium chloride myocardial staining by perfusion.
    Lenihan DJ; McGoron AJ; Gabel M; Walsh RA; Gerson MC
    Invest Radiol; 1999 Apr; 34(4):276-81. PubMed ID: 10196719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium.
    Okada DR; Johnson G; Okada RD
    EJNMMI Res; 2014; 4():42. PubMed ID: 25411652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.